Lupin Limited (LUPIN) Price & Analysis

Compare

11 Followers

LUPIN Stock Chart & Stats

₹1938.85

-₹105.50(-4.47%)

At close: Jan 08 4:00 PM EST

₹1938.85

-₹105.50(-4.47%)

Day’s Range― - ―

52-Week Range₹1,774.00 - ₹2,261.95

Previous CloseN/A

Volume1.35M

Average Volume (3M)25.39K

Market Cap

₹1.02T

Enterprise Value₹1.05T

Total Cash (Recent Filing)₹29.90B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)21.9

Beta0.73

Next Earnings

May 12, 2026

EPS Estimate

23.83

Next Dividend Ex-DateN/A

Dividend Yield0.57%

Share Statistics

EPS (TTM)33.40

Shares Outstanding456,967,960

10 Day Avg. Volume23,417

30 Day Avg. Volume25,387

Financial Highlights & Ratios

PEG Ratio0.38

Price to Book (P/B)5.20

Price to Sales (P/S)3.94

P/FCF Ratio67.94

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹2,460.00

Price Target Upside26.88% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth And Healthy MarginsConsistent double-digit revenue growth coupled with high gross and operating margins indicates structural competitiveness and scale. Sustained margins provide durable cash generation capacity, support reinvestment into R&D and manufacturing, and buffer the business against cyclical pricing pressure.

Healthy Balance Sheet And Strong ROEModerate leverage and a strong equity base with a near-20% ROE signal prudent capital allocation and financial flexibility. This balance sheet strength supports funding for product launches, compliance investment, and selective M&A without excessive refinancing risk over the medium term.

Diversified Business Model Across Products And MarketsMultiple revenue streams across generics, branded India, specialty segments and APIs reduce single-market dependency. This structural diversification smooths cash flow volatility from any one geography or product and supports steady long-term growth through different industry cycles.

Bears Say

Weak Free Cash Flow ConversionSignificant deterioration in free cash flow and low FCF-to-income conversion reduce internal funding for capex, debt paydown, and shareholder returns. Over several quarters this limits strategic flexibility and increases reliance on external financing for growth or acquisitions.

Revenue Exposed To U.S. Generics DynamicsDependence on regulated-market generics launches creates structural revenue volatility and margin pressure from intense competition and contract/tender outcomes. Revenue timing and profitability can be lumpy, complicating long-term forecasting and capital planning.

Low Dividend Yield Limits Income AppealA modest dividend yield reduces attraction to income-focused investors and may limit a stable shareholder base that values cash returns. If management prioritizes reinvestment, this is defensible, but persistent low payouts can constrain investor support during weaker operating cycles.

Lupin Limited News

Lupin Partners with TB Alliance to Advance Telacebec for Tuberculosis and Other Mycobacterial Diseases

Lupin Limited ( ($IN:LUPIN) ) has issued an update. Lupin Limited has entered into a strategic collaboration with...

18d ago

LUPIN

Lupin Strikes Global Semaglutide Deal With Galenicum Across 23 Markets

The latest announcement is out from Lupin Limited ( ($IN:LUPIN) ). Lupin Limited has entered into a licensing...

1M ago

LUPIN

Lupin and PolyPeptide Forge Alliance to Boost Global Peptide Supply Chain

Lupin Limited ( ($IN:LUPIN) ) has shared an announcement. Lupin Manufacturing Solutions, a subsidiary of Lupin Limited, has...

2M ago

LUPIN

Lupin Limited Gains U.S. FDA Approval for First Biosimilar, Armlupeg

Lupin Limited ( ($IN:LUPIN) ) has provided an announcement. Lupin Limited announced that it has received approval from...

3M ago

LUPIN

Lupin Limited Faces FDA Inspection Observations at Goa Facility

Lupin Limited ( ($IN:LUPIN) ) has shared an announcement. Lupin Limited announced that the U.S. FDA conducted an...

3M ago

LUPIN

Lupin Launches First PrecisionSphere™ Product in U.S. with Risperidone Injectable

Lupin Limited ( ($IN:LUPIN) ) has shared an announcement. Lupin Limited has launched Risperidone for extended-release injectable suspension...

3M ago

LUPIN

Lupin Limited Receives U.S. FDA Approval for Aurangabad Facility

The latest update is out from Lupin Limited ( ($IN:LUPIN) ). Lupin Limited announced that it has received...

3M ago

LUPIN

Lupin Bioresearch Center Achieves Zero Observations from U.S. FDA

The latest announcement is out from Lupin Limited ( ($IN:LUPIN) ). Lupin Limited announced that its Bioresearch Center...

3M ago

LUPIN

Lupin Limited’s PEGASUS Study: A New Horizon in Pediatric Myotonic Disorder Treatment

Lupin Limited (($IN:LUPIN)) announced an update on their ongoing clinical study. Study Overview: Lupin Limited is conducting a...

4M ago

LUPIN

Lupin Limited’s ACHILLES Study: A New Horizon in Myotonia Treatment

Lupin Limited (($IN:LUPIN)) announced an update on their ongoing clinical study. Study Overview: Lupin Limited is conducting a...

4M ago

LUPIN

LUPIN FAQ

What was Lupin Limited’s price range in the past 12 months?

Lupin Limited lowest stock price was ₹1774.00 and its highest was ₹2261.95 in the past 12 months.

What is Lupin Limited’s market cap?

Lupin Limited’s market cap is ₹1.02T.

When is Lupin Limited’s upcoming earnings report date?

Lupin Limited’s upcoming earnings report date is May 12, 2026 which is in 81 days.

How were Lupin Limited’s earnings last quarter?

Lupin Limited released its earnings results on Feb 12, 2026. The company reported ₹33.4 earnings per share for the quarter, beating the consensus estimate of ₹27.566 by ₹5.834.

Is Lupin Limited overvalued?

According to Wall Street analysts Lupin Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Lupin Limited pay dividends?

Lupin Limited pays a Annually dividend of ₹12 which represents an annual dividend yield of 0.57%. See more information on Lupin Limited dividends here

What is Lupin Limited’s EPS estimate?

Lupin Limited’s EPS estimate is 23.83.

How many shares outstanding does Lupin Limited have?

Lupin Limited has 456,967,960 shares outstanding.

What happened to Lupin Limited’s price movement after its last earnings report?

Lupin Limited reported an EPS of ₹33.4 in its last earnings report, beating expectations of ₹27.566. Following the earnings report the stock price went up 0.066%.

Which hedge fund is a major shareholder of Lupin Limited?

Currently, no hedge funds are holding shares in IN:LUPIN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Lupin Limited

Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilar and over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. Lupin Limited network consists of 18 labs, 280 LupiMitra collection centers, and 450 pick-up points. It operates in India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Lupin Limited (LUPIN) Earnings & Revenues

Historic Earnings Reports

LUPIN Stock 12 Month Forecast

Average Price Target

₹2,460.00

▲(26.88% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1864":"₹1,864","2461":"₹2,461","2013.25":"₹2,013.3","2162.5":"₹2,162.5","2311.75":"₹2,311.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2460,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹2.46K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2460,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹2.46K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2460,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹2.46K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1864,2013.25,2162.5,2311.75,2461],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2128.6,2154.0923076923077,2179.5846153846155,2205.076923076923,2230.5692307692307,2256.0615384615385,2281.5538461538463,2307.0461538461536,2332.5384615384614,2358.0307692307692,2383.523076923077,2409.0153846153844,2434.507692307692,{"y":2460,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2128.6,2154.0923076923077,2179.5846153846155,2205.076923076923,2230.5692307692307,2256.0615384615385,2281.5538461538463,2307.0461538461536,2332.5384615384614,2358.0307692307692,2383.523076923077,2409.0153846153844,2434.507692307692,{"y":2460,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2128.6,2154.0923076923077,2179.5846153846155,2205.076923076923,2230.5692307692307,2256.0615384615385,2281.5538461538463,2307.0461538461536,2332.5384615384614,2358.0307692307692,2383.523076923077,2409.0153846153844,2434.507692307692,{"y":2460,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2067.95,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1894.43,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1944.32,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2081.72,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1947.75,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1949.19,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1865.45,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1898.55,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1981.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1964.25,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2086.35,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2103.3,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2128.6,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >